1 / 48

Programme

Programme. Where are we now? Current PCT performance within SHA No decision about me, without me: Local patients views Are there w ays of improving care and achieving QIPP? Round table discussion & local implementation plans. Where are we now? Current PCT performance.

tedj
Download Presentation

Programme

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Programme • Where are we now?Current PCT performance within SHA • No decision about me, without me: Local patients views • Are there ways of improving care and achieving QIPP? • Round table discussion & local implementation plans

  2. Where are we now?Current PCT performance Colin Gelder & Sandy Walmsley Respiratory Leads West Midlands

  3. COPD • COPD causes >25,000 deaths a year in England and Wales (5% all deaths) • 835,000 people in England have been diagnosed with COPD • DoH estimate >3 million people have COPD • Thus 2 million have undiagnosed COPD

  4. Key Facts • Approx 9% GP patient population • GP consultation rates x2 angina • Average list will contain 200 COPD patients

  5. NHS Costs

  6. NHS Costs • COPD is an expensive disease for the NHS when it is not identified and treated early • >75% costs is due to severe/very severe patients • Direct cost of COPD to NHS is £810-930 million a year • Without change this is set to grow

  7. Patient Perspective

  8. Patient Perspective • COPD is a progressive illness, and the number of people dying as a result of COPD increases with age • COPD is disabling. Although it affects people in different ways, those with COPD often have breathlessness, reduced exercise tolerance, a cough and repeated chest infections

  9. COPD Exacerbations & Survival 13.9% of people admitted with an exacerbation of COPD die within 90 days 25% of people admitted with an exacerbation of COPD die within 1 year

  10. Social Costs • Quality of life is undermined. • Restricted mobility leads to social isolation and the psychological conditions that go with it. • A British Lung Foundation survey found that 90% of people with severe COPD were unable to participate in socially important activities such as gardening, 66% were unable to take a holiday because of their disease and 33% had disabling breathlessness.

  11. Socio-Economic Bias • Smoking is more prevalent in lower socioeconomic groups • 26% of routine and manual workers smoke vs. 15% in managerial & professional occupations • DoH estimates that the routine and manual occupational group represents 50% people with (diagnosed or undiagnosed) COPD in England • Men aged between 20 and 64 employed in unskilled manual occupations are 14 times more likely to die from COPD than men in professional roles, and are around seven times more likely than those in managerial and technical occupations

  12. The Disadvantaged • The picture is even worse for smokers from the most disadvantaged sectors of society, where in some cases (e.g. for people with schizophrenia) smoking prevalence can reach 74%

  13. Societal Costs • ~25% of people with COPD are prevented from working due to the disease • Leading to 20.4 million lost working days among men and 3.5 million days among women every year • The annual cost of COPD- related lost productivity to employers and the economy has been put at £3.8 billion

  14. Current PerformanceinWest Midlands

  15. PCT Expenditure on RespiratoryDH 2009-10 Programme Budgeting Benchmark Workbook v1.0

  16. PCT Expenditure on RespiratoryDH 2009-10 Programme Budgeting Benchmark Workbook v1.0 National Average of £8.4m, an SHA average of £8.2m

  17. Spend per 100,000 of own population on COPDDH 2009-10 Programme Budgeting Benchmark Workbook v1.0 Note Airways Disease does not include Asthma

  18. Spend per 100,000 of own population on COPDDH 2009-10 Programme Budgeting Benchmark Workbook v1.0 Note Airways Disease does not include Asthma

  19. West Midlands COPD Non-Elective Admissions

  20. Centres with Industry (B) non-elective COPD hospitalisation data

  21. London Cosmopolitan (B) non-elective COPD hospitalisation data

  22. Prospering Smaller Towns (A) non-elective COPD hospitalisation costs

  23. West Midlands non-elective COPD hospitalisation costs

  24. West Midlands non-elective COPD hospitalisation length of stay

  25. West Midlands non-elective COPD hospitalisation 28-day readmission rate

  26. PCT Cost Saving Potentials for COPD

  27. BEN COPD Admissions/1000

  28. HOB COPD Admissions

  29. South Birmingham

  30. Solihull COPD Admissions

  31. West Midlands non-elective Asthma hospitalisation data

  32. Centres with Industry (B) non-elective asthma hospitalisations

  33. London Cosmopolitan (B) non-elective Asthma hospitalisation data

  34. Prospering Smaller Towns (A) non-elective asthma hospitalisation data

  35. West Midlands non-elective Asthma hospitalisation costs

  36. West Midlands non-elective Asthma hospitalisation length of stay

  37. West Midlands non-elective Asthma hospitalisation 28-day readmission rate

  38. PCT Cost saving Potential for Asthma

  39. BEN Asthma Admissions

  40. HOB Asthma Admissions

  41. South Birmingham Asthma Admissions

  42. Solihull Asthma Admissions

More Related